All Stories

  1. Aerotoxic syndrome
  2. Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia
  3. Relación de las profesiones y las condiciones laborales con la neumonía adquirida en la comunidad
  4. Passive smoking at home is a risk factor for community-acquired pneumonia in older adults: a population-based case-control study
  5. Relationship between the Use of Inhaled Steroids for Chronic Respiratory Diseases and Early Outcomes in Community-Acquired Pneumonia
  6. Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy
  7. Outcomes in females hospitalised with community-acquired pneumonia are worse than in males
  8. Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
  9. Predictive accuracy of the pneumonia severity index vs CRB-65 for time to clinical stability: Results from the Community-Acquired Pneumonia Organization (CAPO) International Cohort Study
  10. Inhaled drugs as risk factors for community-acquired pneumonia
  11. Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer
  12. Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials
  13. LABA
  14. New evidence of risk factors for community-acquired pneumonia: a population-based study
  15. Neglected Respiratory Toxicity Caused by Cancer Therapy
  16. 13 – Antibiotic therapy of community-acquired pneumonia (CAP) caused by atypical agents
  17. Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia
  18. Fluoroquinolones vs Macrolides in the Treatment of Legionnaires Disease
  19. Legionnaires Disease and the Updated IDSA Guidelines for Community‐Acquired Pneumonia
  20. Legionnaires' disease: a rational approach to therapy
  21. Serological evidence ofLegionellaspecies infection in acute exacerbation of COPD
  22. Is serological diagnosis of legionnaires’ disease a reliable method?
  23. ¿Está justificada la inclusión de levofloxacino en el tratamiento antibiótico empírico de las exacerbaciones de la enfermedad pulmonar obstructiva crónica leve, en pacientes sin comorbilidad y menores de 65 años?
  24. Preresectional chemotherapy in stage IIIA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial
  25. Inhaled antibiotic therapy in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection by Pseudomonas aeruginosa
  26. Evaluation of the Use of Three Different Devices for Nocturnal Oxygen Therapy in COPD Patients
  27. Catéter transtraqueal y oxígeno líquido: 5 años de experiencia
  28. Legionnaires’ Disease
  29. A Randomized Trial Comparing Preoperative Chemotherapy Plus Surgery with Surgery Alone in Patients with Non-Small-Cell Lung Cancer
  30. Bronchial Stump Aspergillosis Four Years After Lobectomy
  31. Treatment of Legionnaires?? Disease
  32. Acute Eosinophilic Pneumonia due to Toxocariasis with Bronchoalveolar Lavage Findings
  33. Usefulness of supraclavicular ultrasonography in the staging of lung cancer
  34. Pulmonary Capillary Hemangiomatosis: Report of a Case and Review of the Literature
  35. Radiographic appearance of nosocomial legionnaires' disease after erythromycin treatment.
  36. Adult Human Toxocariasis Acquired by Eating Raw Snails
  37. Pulmonary Mass and Air Meniscus Sign in a 19-Year-Old Man
  38. The use of corticosteroids in the control of the adverse effects of cotrimoxazole in AIDS patients suffering from PCP
  39. Comparative Study of Legionella pneumophila and Other Nosocomial-Acquired Pneumonias
  40. Prevention of Recurrent Pulmonary Embolism
  41. Tuberculosis of the breast: a rare modern disease
  42. Variation in Maximum Inspiratory and Expiratory Pressure after Application of Inspiratory Loads in Patients with COPD
  43. Postural Variation of the Maximum Inspiratory and Expiratory Pressures in Normal Subjects
  44. Pericardial effusion as a clinical sign of legionnaires' disease